Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yumiko Iba is active.

Publication


Featured researches published by Yumiko Iba.


Fertility and Sterility | 2003

Gonadotropin-releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriomas

Tomio Iwabe; Tasuku Harada; Yasuko Sakamoto; Yumiko Iba; Sayako Horie; Masahiro Mitsunari; Naoki Terakawa

OBJECTIVE To determine whether serum interleukin (IL)-6 can be measured in patients with ovarian endometriomas and whether these measurements are useful in managing this disease. DESIGN A controlled clinical study and an in vitro study. SETTING Department of Obstetrics and Gynecology, Tottori University, Japan.Twenty-two patients with ovarian endometriomas. INTERVENTION(S) Laparoscopic cystectomy for ovarian endometriomas was performed. Gonadotropin-releasing hormone (GnRH) agonist was administered for 3 months in nine patients before laparoscopic surgery. Endometriotic stromal cells obtained from patients with endometriomas with or without GnRH agonist treatment were cultured. MAIN OUTCOME MEASURES(S) IL-6 concentrations in serum or supernatant of the cell culture were measured using ELISA. RESULTS The serum concentration of IL-6 in patients with endometriomas was higher at the time of diagnosis than in those without endometriomas. Laparoscopic surgery significantly reduced serum levels of IL-6. Serum IL-6 concentrations also decreased after treatment with GnRH agonist. IL-6 production was attenuated in the endometriotic stromal cells obtained from patients with GnRH agonist treatment compared with patients without such treatment. CONCLUSION(S) GnRH agonist treatment may decrease IL-6 production in endometriotic cells. Measurement of serum IL-6 concentrations may be of value in managing patients with endometriomas.


Journal of Obstetrics and Gynaecology Research | 2018

The efficacy and safety of dydrogesterone for treatment of dysmenorrhea: An open-label multicenter clinical study: Dydrogesterone for dysmenorrhea

Fuminori Taniguchi; Ikuko Ota; Yumiko Iba; Toshiko Toda; Yukiko Tagashira; Yorie Ohata; Hiroko Kurioka; Yusuke Endo; Hiroshi Sunada; Hisashi Noma; Yukihiro Azuma; Tasuku Harada

Dydrogesterone is a retro‐progesterone preparation widely used for over a half century. We sought to evaluate the efficacy and safety of dydrogesterone in Japanese women with dysmenorrhea.


Journal of Ultrasound in Medicine | 2016

Concordant Body Stalk Anomalies in Dichorionic Twins.

Takahiro Iba; Takashi Harada; Yumiko Iba; Kyoko Nishikori; Tomio Iwabe; Tasuku Harada; Yasuyuki Mio

A body stalk anomaly is a sporadic and rare condition characterized by serious defects of the abdominal wall and spine.1 It is often diagnosed on the basis of sonographic findings, such as substantial disruption of the anterior abdominal wall, severe kyphoscoliosis, and an obviously short umbilical cord; however, the mechanism of its development has not yet been elucidated. The estimated incidence of body stalk anomalies is 1 per 7500 women undergoing sonography during the first trimester of pregnancy.2 Body stalk anomalies in twins are extremely rare,3 and to date, there are no reported cases of body stalk anomalies in both fetuses in a dichorionic twin pregnancy. Here we report an extremely rare case of body stalk anomalies in both fetuses of a dichorionic twin pregnancy. The patient, a 31-year-old woman, gravida 1, visited our infertility clinic in January 2014. She had no notable personal and family histories. She conceived after treatment with clomiphene citrate, human menopausal gonadotropin, and human chorionic gonadotropin. At 6 weeks’ gestation, 2 gestational sacs were seen in the uterus, and an embryo and embryonic heartbeats were confirmed in each gestational sac. Determination of chorionicity by sonography revealed a dichorionic twin pregnancy. At 8 weeks’ gestation, the crown-rump lengths were 18.6 and 18.5 mm, and no abnormalities were detected. At 9 weeks’ gestation, the crown-rump lengths were 25 and 22 mm. At this time, the expected date of delivery was calculated on the basis of a crown-rump length of 22 mm. At 11 weeks’ gestation, one fetus showed nuchal translucency of 6.2 mm. In addition, the fetus also had a deformity of the ventral wall, and the clinical course was carefully followed, considering the possibility of physiologic omphalocele. At 12 weeks’ gestation, both fetuses showed prominent nuchal translucency and a deformity of the ventral wall, and the patient was referred to the university hospital for a further detailed examination. At the first visit to the university hospital, at 13 weeks’ gestation, marked nuchal translucency was detected in both fetuses. In addition, the examination raised the suspicion of omphalocele. At 15 weeks’ gestation, sonography revealed organs protruding from the abdomen, kyphoscoliosis and flexure of the lower extremities, and a short umbilical cord, based on which the diagnosis of a body stalk anomaly was made (Figure 1, A and B). Because of the extremely poor prognosis of the body stalk anomaly, an abortion was performed at 16 weeks’ gestation. In the first fetus, the amnion was attached to the fetus, and the organs prolapsed outside the abdominal cavity, Clinical Letters


The Journal of Clinical Endocrinology and Metabolism | 2003

Tumor Necrosis Factor-α-Induced Interleukin-8 (IL-8) Expression in Endometriotic Stromal Cells, Probably through Nuclear Factor-κB Activation: Gonadotropin-Releasing Hormone Agonist Treatment Reduced IL-8 Expression

Yasuko Sakamoto; Tasuku Harada; Sayako Horie; Yumiko Iba; Fuminori Taniguchi; Souichi Yoshida; Tomio Iwabe; Naoki Terakawa


The Journal of Clinical Endocrinology and Metabolism | 2004

Hepatocyte growth factor/Met system promotes endometrial and endometriotic stromal cell invasion via autocrine and paracrine pathways.

Souichi Yoshida; Tasuku Harada; Masahiro Mitsunari; Tomio Iwabe; Yasuko Sakamoto; Satoru Tsukihara; Yumiko Iba; Sayako Horie; Naoki Terakawa


Fertility and Sterility | 2004

Lipopolysaccharide-promoted proliferation of endometriotic stromal cells via induction of tumor necrosis factor α and interleukin-8 expression

Yumiko Iba; Tasuku Harada; Sayako Horie; Imari Deura; Tomio Iwabe; Naoki Terakawa


Fertility and Sterility | 2010

Analysis of compaction initiation in human embryos using time-lapse cinematography

C.H. Sargent; K. Iwata; Y. Kai; A. Imajo; K. Yumoto; Yumiko Iba; Yasuyuki Mio


Fertility and Sterility | 2012

Dynamic Analysis of the Relationship Between the Collapse of Blastulation and Hatching in Human Blastocysts Using Time-Lapse Cinematography

K. Yumoto; K. Iwata; C.H. Sargent; Y. Kai; A. Imajyo; Yumiko Iba; Yasuyuki Mio


Fertility and Sterility | 2015

Cumulative pregnancy rate based on the number of embryo transfers in assisted reproductive technologies

Yasuyuki Mio; K. Iwata; K. Yumoto; C. Mizoguchi; M. Sugishima; M. Tsuneto; Yumiko Iba


Fertility and Sterility | 2013

Discrimination of maternally or paternally derived pronuclei by epigenetic divergence in human zygotes

Y. Kai; H.C. Sargent; K. Iwata; K. Yumoto; Yumiko Iba; Yasuyuki Mio

Collaboration


Dive into the Yumiko Iba's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge